Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$207K Sell
934
-708
-43% -$164K ﹤0.01% 491
2023
Q1
$416K Buy
1,642
+75
+5% +$18.4K 0.01% 397
2022
Q4
$412K Buy
1,567
+27
+2% +$7.24K 0.01% 377
2022
Q3
$347K Buy
1,540
+307
+25% +$74.4K 0.01% 375
2022
Q2
$300K Buy
1,233
+392
+47% +$96.1K 0.01% 382
2022
Q1
$203K Buy
+841
New +$193K ﹤0.01% 404
2021
Q1
– Sell
-2,466
Closed -$586K – 352
2020
Q4
$586K Sell
2,466
-23,495
-91% -$5.42M 0.02% 272
2020
Q3
$6.6M Buy
25,961
+3,423
+15% +$848K 0.22% 101
2020
Q2
$5.32M Buy
22,538
+3,476
+18% +$793K 0.2% 107
2020
Q1
$3.86M Buy
19,062
+4,762
+33% +$1.04M 0.17% 97
2019
Q4
$3.45M Buy
14,300
+3,527
+33% +$777K 0.13% 111
2019
Q3
$2.08M Buy
10,773
+3,182
+42% +$611K 0.09% 116
2019
Q2
$1.41M Buy
7,591
+4,279
+129% +$766K 0.06% 116
2019
Q1
$629K Buy
+3,312
New +$632K 0.03% 119

Other funds holding AMGN

PFS Investments's AMGN Position: Q2 2023 in Review

PFS Investments reduced its Amgen (AMGN) stake by 43% in Q2 2023, selling an estimated $164K and leaving 934 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

PFS Investments first reported a position in AMGN in Q1 2019 and has held it in 14 quarters since. The position peaked at $6.6M in Q3 2020. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • PFS Investments held 934 shares of Amgen worth $207K as of Q2 2023.
  • PFS Investments sold 708 Amgen shares in Q2 2023, an estimated $164K.
  • Amgen made up ﹤0.01% of PFS Investments's portfolio in Q2 2023, its #491 holding.
  • PFS Investments first reported a position in Amgen in Q1 2019 and has held it in 14 quarters since.
  • PFS Investments's Amgen position peaked at $6.6M in Q3 2020.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on PFS Investments's 13F filing for Q2 2023, filed 14 Aug 2023.